Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

Lartruvo Phase III Fail Rocks Lilly Oncology Plans

Mon, 01/21/2019 - 5:50am

It looks like the end for Latruvo after a late-stage trial in soft tissue sarcoma patients did not confirm the...

      Related Stories 

Deal Watch: Celgene Makes Alliances With Kyn, Obsidian After Bristol Buyout

Sun, 01/20/2019 - 11:19pm

Just two weeks after agreeing on a merger with Bristol, Celgene is back at its own deal-making, signing cancer-focused R&D...

      Related Stories 

Pipeline Watch: Phase II Results With ZGN-1061 And OMS721

Sun, 01/20/2019 - 11:13pm

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...

      Related Stories 

Aum Bets On Asia-To-Global Oncology Model

Sun, 01/20/2019 - 10:44pm

Emerging Company Profile: Singapore-based Aum Biosciences hopes to disrupt early stage oncology drug development with an Asia-pivoted model, and the...

      Related Stories 

Rare But Real: How One Startup Is Willing Itself To Lift China Orphan Drug Market

Sun, 01/20/2019 - 7:35pm

As a promising market for orphan drugs, China has seen several approvals in this space in the past six months...

      Related Stories 

Q4 Pharma Earnings Preview: J&J, Bristol And AbbVie

Fri, 01/18/2019 - 1:03pm

Johnson & Johnson has solid growth drivers in pharmaceuticals, but still faces an overhang related to talc controversy; Bristol's call...

      Related Stories 

Dark Days For Sun As Governance Saga Escalates

Fri, 01/18/2019 - 7:01am

Allegations of corporate governance lapses continued to singe Sun, but there is little clarity on which way things are headed...

      Related Stories 

Catalan Biotechs Boosted By International Backers

Fri, 01/18/2019 - 6:41am

The number of foreign investors participating in Catalan biotech companies has gone from 0 to 50, and over the past...

      Related Stories 

Finance Watch: VC Deals Keep Up Fast Pace With $1.1bn In Less Than Three Weeks

Thu, 01/17/2019 - 3:21pm

Finance Watch has noted $1.1bn worth of venture capital deals so far in 2019. Meanwhile, public offerings continue to be...

      Related Stories 

Spectrum Reshuffles Focus, Selling Seven Products To Aurobindo

Thu, 01/17/2019 - 12:31pm

By selling seven approved oncology/hematology products to a US affiliate of Aurobindo, Spectrum gets cash to increase focus on late-stage...

      Related Stories 

Lilly/Loxo Deal Came Together Quickly

Thu, 01/17/2019 - 11:15am

Lilly's $8bn acquisition of genetics-based cancer specialist Loxo Oncology didn't involve any other bidders and was finalized in just days...

      Related Stories 

J&J’s Erleada Gives Chase To Xtandi For Non-Metastatic Prostate Cancer With Approval In Europe

Thu, 01/17/2019 - 8:27am

Astellas/Pfizer’s Xtandi and Johnson & Johnson’s Erleada are both now approved for non-metastatic castration-resistant prostate cancer in Europe, while Xtandi...

      Related Stories 

Pages